From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Why is James Cherry from lawyers Simmons & Simmons running scared of me?

By Tom Winnifrith | Wednesday 21 February 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with the chicken lawyer, JP Jenkins not explaining a share suspension and Tintra (TNT), the AIM Company of the year 2022, which might have been wound up this morning. Then it is Ariana Resources (AAU), Amaroq (AMRQ) my biggest gold holding which will be 100p+ well before Christmas, Faron Pharmaceutics (FARN), Bytes Technology (BYIT) and its very naughty now ex CEO Neil Murphy and today's ouzo moment from Shield Therapeutics (STX). I still await apologies from the trolls of 2022 as I drink gallons of vindication. 
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 08:12:19